Many of our global manufacturers have developed important research tools to understand host immune response.
We offer COVID-19 research tools from the following manufacturers:
InvivoGen provides the largest choice of vaccine adjuvants.
They are either already approved for use in human vaccination or still under investigation. They include particulate adjuvants, such as alum and emulsions, and molecules known to activate pattern recognition receptors (PRR), referred to as PRR agonists. Adjuvants are essential for enhancing and directing the adaptive immune response to vaccine antigens. They not only potentiate the immunogenicity and protection efficacy of vaccines, but they also help to avoid an exacerbated TH2-polarized response.
For more information, please visit: https://www.invivogen.com/vaccine-adjuvants